Resultados de la búsqueda

Coats CJ, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Maron MS, Miao ZM, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, German P, Heitner SB, Kupfer S, Lutz JD, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA‐HCM Investigators. Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. J Am Heart Assoc (2024) 13:e035993

de Frutos F, Ochoa JP, Webster G, Jansen M, Remior P, Rasmussen TB, Sabater-Molina M, Barriales-Villa R, Girolami F, Cesar S, Fuentes-Cañamero ME, Alvarez García-Rovés R, Wahbi K, Limeres J, Kubanek M, Slieker MG, Sarquella-Brugada G, Abrams DJ, Dooijes D, Domínguez F, Garcia-Pavia P; European Genetic Cardiomyopathies Initiative Investigators. Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy. J Am Heart Assoc (2024) 13:e036208.

Masri A, Sherrid MV, Abraham TP, Choudhury L, Garcia-Pavia P, Kramer CM, Barriales-Villa R, Owens AT, Rader F, Nagueh SF, Olivotto I, Saberi S, Tower-Rader A, Wong TC, Coats CJ, Watkins H, Fifer MA, Solomon SD, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Meng L, Sohn RL, Wohltman A, Maron MS; REDWOOD-HCM Investigators. Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4. J Card Fail (2024) S1071-9164:00082-4
Link to the full text in Repisalud

Garcia-Pavia P, Kristen AV, Drachman B, Carlsson M, Amass L, Angeli FS, Maurer MS; THAOS investigators. Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS). J Card Fail (2024) S1071-9164:00222-7
Link to the full text in Repisalud

Maron MS, Abraham T, Coats CJ, Olivotto I, Lee MY, Arad M, Cardim N, Ma CS, Choudhury L, Düngen HD, Garcia-Pavia P, Hagege A, Lewis GD, Michels M, Oreziak A, Owens AT, Tfelt-Hansen J, Veselka J, Watkins HC, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Meng L, Wohltman A, Masri A Baseline Characteristics of Patients in SEQUOIA-HCM: APhase 3 Trial of Aficamten in Obstructive Hypertrophic Cardiomyopathy. J Card Fail (2024) 30:S3-S3

Maurer MS, Soman P, Hernandez A, Garcia-Pavia P, Signorovitch J, Wei LJ, Hanna M, Ruberg FL, Kittleson M, Kazi D, Dorbala S, Hsu K, Lousada I, Adigun R, Dunnmon P, Kelly J, Gillmore J; Amyloidosis Forum Meeting Panelists. Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. ADV THER (2024) 41:2723-2742.

Gómez González C, Del Campo Cano I, Isabel Fernández-Avila A, Paz Suárez-Mier M, José Sagastizábal M, Álvarez García-Rovés R, Méndez Fernández I, Vilches S, Centeno Jiménez M, Siles Sánchez-Manjavacas A, Usano Carrasco A, Gonzalez-Vioque E, Pablo Ochoa J, Medrano C, González López E, García-Pavía P, Bermejo J, Angeles Espinosa Castro M. Sudden cardiac death triggered by minimal alcohol consumption in the context of novel PPA2 mutations in 2 unrelated families GENE (2024) 916:148437
Link to the full text in Repisalud

Carrera IA, Amor-Salamanca A, Isidro EM, Pérez-Barbeito M, Sacristán ARB, Ochoa JP. Double somatic mosaicism in Marfan syndrome. AM J MED GENET A (2024) 194:e63831

Pham-Trung C, Veloza-Urrea D, Segura-Domínguez M, De la Rosa Rojas Y, Aguilera-Agudo C, García-Izquierdo EA, García-Rodríguez D, Jiménez-Sánchez D, Lorente-Ros A, Mingo-Santos S, Gonzalez-Lopez E, Domínguez F, Garcia-Pavia P, Toquero-Ramos J, Fernández-Lozano I, Castro-Urda V. Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience. Pacing Clin Electrophysiol (2024) 47:149-155

Shah SJ, Fine N, Garcia-Pavia P, Klein AL, Fernandes F, Weissman NJ, Maurer MS, Boman K, Gundapaneni B, Sultan MB, Elliott P. Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. J JAMA Cardiol (2024) 9:25-34.
Link to the full text in Repisalud